| 1 |
Ford AC, Marwaha A, Sood R，et al.Global prevalence of，and risk factors for，uninvestigated dyspepsia：a meta-analysis.Gut，2015，64(7):1049-1057.
|
| 2 |
Stanghellini V, Chan FK, Hasler WL，et al.Gastroduodenal Disorders.Gastroenterology，2016，150(6):1380-1392.
|
| 3 |
Futagami S, Yamawaki H, Agawa S，et al.New classification Rome IV functional dyspepsia and subtypes.Transl Gastroenterol Hepatol，2018，3:70-72.
|
| 4 |
Futagami S, Yamawaki H, Hashimoto S，et al.New horizon of the pathophysiology of functional dyspepsia.Nihon Shokakibyo Gakkai Zasshi，2016，113(6):927-935.
|
| 5 |
Camilleri M, Stanghellini V．Current management strategies and emerging treatments for functional dyspepsia.Nat Rev Gastroenterol Hepatol，2013，10(3):187-194.
|
| 6 |
Lacy BE, Talley NJ, Locke GR, 3rd，et al.Review article：current treatment options and management of functional dyspepsia.Aliment Pharmacol Ther，2012，36(1):3-15.
|
| 7 |
Takahashi T．Interdigestive migrating motor complex-its mechanism and clinical importance.J Smooth Muscle Res，2013，49:99-111.
|
| 8 |
Takahashi T．Mechanism of interdigestive migrating motor complex.J Neurogastroenterol Motil，2012，18(3):246-257.
|
| 9 |
Asano H, Tomita T, Nakamura K，et al.Prevalence of Gastric Motility Disorders in Patients with Functional Dyspepsia.J Neurogastroenterol Motil，2017，23(3):392-399.
|
| 10 |
Pittayanon R, Yuan Y, Bollegala NP，et al.Prokinetics for Functional Dyspepsia：A Systematic Review and Meta-Analysis of Randomized Control Trials.Am J Gastroenterol，2019，114(2):233-243.
|
| 11 |
Janssen P, Harris MS, Jones M，et al.The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.Am J Gastroenterol，2013，108(9):1382-1391.
|
| 12 |
Current Opinion in Gastroenterology.Current world literature.Curr Opin Gastroenterol，2009，25(1):74-85.
|
| 13 |
Keohane J, Quigley EM.Functional dyspepsia：the role of visceral hypersensitivity in its pathogenesis.World J Gastroenterol，2006，12(17):2672-2676.
|
| 14 |
Hammer J, Fuhrer M, Pipal L，et al.Hypersensitivity for capsaicin in patients with functional dyspepsia.Neurogastroenterol Motil，2008，20(2):125-133.
|
| 15 |
Grundy D．5-HT system in the gut：roles in the regulation of visceral sensitivity and motor functions.Eur Rev Med Pharmacol Sci，2008，12 Suppl 1:63-67.
|
| 16 |
Geeraerts B, Vandenberghe J, Van Oudenhove L，et al.Influence of experimentally induced anxiety on gastric sensorimotor function in humans.Gastroenterology，2005，129(5):1437-1444.
|
| 17 |
Ma G, Hu P, Zhang B，et al.Transcutaneous electrical acustimulation synchronized with inspiration improves gastric accommodation impaired by cold stress in healthy subjects.Neurogastroenterol Motil，2019，31(2):e13491.
|
| 18 |
Van Oudenhove L, Vandenberghe J, Geeraerts B，et al.Determinants of symptoms in functional dyspepsia：gastric sensorimotor function，psychosocial factors or somatisation? Gut，2008，57(12):1666-1673.
|
| 19 |
Geeraerts B, Van Oudenhove L, Fischler B，et al.Influence of abuse history on gastric sensorimotor function in functional dyspepsia.Neurogastroenterol Motil，2009，21(1):33-41.
|
| 20 |
Hartono JL, Mahadeva S, Goh KL.Anxiety and depression in various functional gastrointestinal disorders：do differences exist? J Dig Dis，2012，13(5):252-257.
|
| 21 |
Bouchoucha M, Hejnar M, Devroede G，et al.Anxiety and depression as markers of multiplicity of sites of functional gastrointestinal disorders：a gender issue? Clin Res Hepatol Gastroenterol，2013，37(4):422-430.
|
| 22 |
Browning KN, Travagli RA.Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.Compr Physiol，2014，4(4):1339-1368.
|
| 23 |
Koloski NA, Jones M, Kalantar J，et al.The brain--gut pathway in functional gastrointestinal disorders is bidirectional：a 12-year prospective population-based study.Gut，2012，61(9):1284-1290.
|
| 24 |
Liu P, Wang G, Zeng F，et al.Abnormal brain structure implicated in patients with functional dyspepsia.Brain Imaging Behav，2018，12(2):459-466.
|
| 25 |
Lee KJ, Tack J．Duodenal implications in the pathophysiology of functional dyspepsia.J Neurogastroenterol Motil，2010，16(3):251-257.
|
| 26 |
Miwa H, Oshima T, Tomita T，et al.Recent understanding of the pathophysiology of functional dyspepsia：role of the duodenum as the pathogenic center.J Gastroenterol，2019，54(4):305-311.
|
| 27 |
Lee KJ, Demarchi B, Demedts I，et al.A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea.Am J Gastroenterol，2004，99(9):1765-1773.
|
| 28 |
Bratten J, Jones MP.Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system.J Clin Gastroenterol，2009，43(6):527-533.
|
| 29 |
Bharucha AE, Camilleri M, Burton DD，et al.Increased nutrient sensitivity and plasma concentrations of enteral hormones during duodenal nutrient infusion in functional dyspepsia.Am J Gastroenterol，2014，109(12):1910-1920.
|
| 30 |
Oshima T, Okugawa T, Tomita T，et al.Generation of dyspeptic symptoms by direct acid and water infusion into the stomachs of functional dyspepsia patients and healthy subjects.Aliment Pharmacol Ther，2012，35(1):175-182.
|
| 31 |
Vanheel H, Vicario M, Vanuytsel T，et al.Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia.Gut，2014，63(2):262-271.
|
| 32 |
Tanaka F, Tominaga K, Fujikawa Y，et al.Concentration of Glial Cell Line-Derived Neurotrophic Factor Positively Correlates with Symptoms in Functional Dyspepsia.Dig Dis Sci，2016，61(12):3478-3485.
|
| 33 |
Du L, Shen J, Kim JJ，et al.Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia：A Prospective Study.Sci Rep，2016，6:34305.
|
| 34 |
Osadchiy V, Martin CR, Mayer EA.The Gut-Brain Axis and the Microbiome：Mechanisms and Clinical Implications.Clin Gastroenterol Hepatol，2019，17(2):322-332.
|
| 35 |
Quigley EMM.The Gut-Brain Axis and the Microbiome：Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome(IBS)．J Clin Med，2018，7(1):6-13.
|
| 36 |
Zhong L, Shanahan ER, Raj A，et al.Dyspepsia and the microbiome：time to focus on the small intestine.Gut，2017，66(6):1168-1169.
|
| 37 |
Igarashi M, Nakae H, Matsuoka T，et al.Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia.BMJ Open Gastroenterol，2017，4(1):e000144.
|
| 38 |
Lembo A, Pimentel M, Rao SS，et al.Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.Gastroenterology，2016，151(6):1113-1121.
|
| 39 |
Kimer N, Krag A, Moller S，et al.Systematic review with meta-analysis：the effects of rifaximin in hepatic encephalopathy.Aliment Pharmacol Ther，2014，40(2):123-132.
|
| 40 |
Tan VP, Liu KS, Lam FY，et al.Randomised clinical trial：rifaximin versus placebo for the treatment of functional dyspepsia.Aliment Pharmacol Ther，2017，45(6):767-776.
|
| 41 |
Mazzoleni LE, Sander GB, Francesconi CF，et al.Helicobacter pylori eradication in functional dyspepsia：HEROES trial.Arch Intern Med，2011，171(21):1929-1936.
|
| 42 |
Kim SE, Park YS, Kim N，et al.Effect of Helicobacter pylori Eradication on Functional Dyspepsia.J Neurogastroenterol Motil，2013，19(2):233-243.
|
| 43 |
Lan L, Yu J, Chen YL，et al.Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia.World J Gastroenterol，2011，17(27):3242-3247.
|
| 44 |
Xu S, Wan X, Zheng X，et al.Symptom improvement after helicobacter pylori eradication in patients with functional dyspepsia-A multicenter，randomized，prospective cohort study.Int J Clin Exp Med，2013，6(9):747-756.
|
| 45 |
Sugano K, Tack J, Kuipers EJ, faculty members of Kyoto Global Consensus C．Kyoto global consensus report on Helicobacter pylori gastritis.Gut，2015，64(9):1353-1367.
|
| 46 |
Talley NJ, Ford AC.Functional Dyspepsia.N Engl J Med，2015，373(19):1853-1863.
|
| 47 |
Jodaki A, Sahraie A, Yasemi M，et al.Helicobacter pylori eradication effect on patients with functional dyspepsia symptoms.Minerva Gastroenterol Dietol，2016，62(2):148-154.
|
| 48 |
Zhao W, Zhong X, Zhuang X，et al.Evaluation of Helicobacter pylori eradication and drug therapy in patients with functional dyspepsia.Exp Ther Med，2013，6(1):37-44.
|
| 49 |
Tack J, Camilleri M．New developments in the treatment of gastroparesis and functional dyspepsia.Curr Opin Pharmacol，2018，43:111-117.
|
| 50 |
Masuy I, Van Oudenhove L, Tack J．Review article：treatment options for functional dyspepsia.Aliment Pharmacol Ther，2019，49(9):1134-1172.
|
| 51 |
Hongo M, Harasawa S, Mine T，et al.Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone：Japan Mosapride Mega-Study(JMMS)．J Gastroenterol Hepatol，2012，27(1):62-68.
|
| 52 |
Curran MP, Robinson DM.Mosapride in gastrointestinal disorders.Drugs，2008，68(7):981-991.
|
| 53 |
Uchida M, Yamato S, Shimizu K，et al.Dual role of mosapride citrate hydrate on the gastric emptying evaluated by the breath test in conscious rats.J Pharmacol Sci，2013，121(4):282-287.
|
| 54 |
Keto Y, Hirata T, Takemoto Y，et al.Influence of gastric acid on gastric emptying and gastric distension-induced pain response in rats--effects of famotidine and mosapride.Neurogastroenterol Motil，2012，24(2):147-153.
|
| 55 |
Masuy I, Carbone F, Holvoet L，et al.The effect of rikkunshito on gastrointestinal symptoms and gastric motor function：The first study in a Belgian functional dyspepsia population.Neurogastroenterol Motil，2020，32(2):e13739.
|
| 56 |
Hallerback BI, Bommelaer G, Bredberg E，et al.Dose finding study of mosapride in functional dyspepsia：a placebo-controlled，randomized study.Aliment Pharmacol Ther，2002，16(5):959-967.
|
| 57 |
Tack J, Van den Houte K, Carbone F．The Unfulfilled Promise of Prokinetics for Functional Dyspepsia/Postprandial Distress Syndrome.Am J Gastroenterol，2019，114(2):204-206.
|
| 58 |
Hiyama T, Yoshihara M, Matsuo K，et al.Treatment of functional dyspepsia with serotonin agonists：a meta-analysis of randomized controlled trials.J Gastroenterol Hepatol，2007，22(10):1566-1570.
|
| 59 |
Tegaserod：withdrawal from the world market.A treatment for constipation with cardiovascular adverse effects.Prescrire Int，2008，17(95):112-113.
|
| 60 |
Griffin JP.Prepulsid withdrawn from UK & US markets.Adverse Drug React Toxicol Rev，2000，19(3):177.
|
| 61 |
Ehlert FJ, Pak KJ, Griffin MT.Muscarinic agonists and antagonists：effects on gastrointestinal function.Handb Exp Pharmacol，2012，(208):343-374.
|
| 62 |
Ikeo K, Oshima T, Sei H，et al.Acotiamide improves stress-induced impaired gastric accommodation.Neurogastroenterol Motil，2017，29(4):e12991.
|
| 63 |
Shinozaki S, Osawa H, Sakamoto H，et al.The effect of acotiamide on epigastric pain syndrome and postprandial distress syndrome in patients with functional dyspepsia.J Med Invest，2016，63(3-4):230-235.
|
| 64 |
Ogishima M, Kaibara M, Ueki S，et al.Z-338 facilitates acetylcholine release from enteric neurons due to blockade of muscarinic autoreceptors in guinea pig stomach.J Pharmacol Exp Ther，2000，294(1):33-37.
|
| 65 |
Altan E, Masaoka T, Farre R，et al.Acotiamide，a novel gastroprokinetic for the treatment of patients with functional dyspepsia：postprandial distress syndrome.Expert Rev Gastroenterol Hepatol，2012，6(5):533-544.
|
| 66 |
Matsueda K, Hongo M, Tack J，et al.A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia.Gut，2012，61(6):821-828.
|
| 67 |
Veldhuyzen van Zanten SJ, Chiba N，et al.A randomized trial comparing omeprazole，ranitidine，cisapride，or placebo in helicobacter pylori negative，primary care patients with dyspepsia：the CADET-HN Study.Am J Gastroenterol，2005，100(7):1477-1488.
|
| 68 |
Sakurai K, Nagahara A, Inoue K，et al.Efficacy of omeprazole，famotidine，mosapride and teprenone in patients with upper gastrointestinal symptoms：an omeprazole-controlled randomized study(J-FOCUS)．BMC Gastroenterol，2012，12:42-53.
|
| 69 |
Moayyedi P, Delaney BC, Vakil N，et al.The efficacy of proton pump inhibitors in nonulcer dyspepsia：a systematic review and economic analysis.Gastroenterology，2004，127(5):1329-1337.
|
| 70 |
Pinto-Sanchez MI, Yuan Y, Hassan A，et al.Proton pump inhibitors for functional dyspepsia.Cochrane Database Syst Rev，2017，11(11):CD011194.
|
| 71 |
Laine L, Ahnen D, McClain C，et al.Review article：potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.Aliment Pharmacol Ther，2000，14(6):651-668.
|
| 72 |
Tougas G, Earnest DL, Chen Y，et al.Omeprazole delays gastric emptying in healthy volunteers：an effect prevented by tegaserod.Aliment Pharmacol Ther，2005，22(1):59-65.
|
| 73 |
Van Oudenhove L, Vandenberghe J, Geeraerts B，et al.Relationship between anxiety and gastric sensorimotor function in functional dyspepsia.Psychosom Med，2007，69(5):455-463.
|
| 74 |
Farre R, Vanheel H, Vanuytsel T，et al.In functional dyspepsia，hypersensitivity to postprandial distention correlates with meal-related symptom severity.Gastroenterology，2013，145(3):566-573.
|
| 75 |
Jones MP, Talley NJ, Eslick GD，et al Community subgroups in dyspepsia and their association with weight loss.Am J Gastroenterol，2008，103(8):2051-2060.
|
| 76 |
Simren M, Tornblom H, Palsson OS，et al.Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders：consistent findings from five different patient cohorts.Gut，2018，67(2):255-262.
|
| 77 |
Tack J, Broekaert D, Coulie B，et al.Influence of the selective serotonin re-uptake inhibitor，paroxetine，on gastric sensorimotor function in humans.Aliment Pharmacol Ther，2003，17(4):603-608.
|
| 78 |
Chial HJ, Camilleri M, Burton D，et al.Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.Am J Physiol Gastrointest Liver Physiol，2003，284(1):G130-137.
|
| 79 |
Talley NJ, Locke GR, Saito YA，et al.Effect of Amitriptyline and Escitalopram on Functional Dyspepsia：A Multicenter，Randomized Controlled Study.Gastroenterology，2015，149(2):340-349.
|
| 80 |
Drossman DA, Tack J, Ford AC，et al.Neuromodulators for Functional Gastrointestinal Disorders(Disorders of Gut-Brain Interaction)：A Rome Foundation Working Team Report.Gastroenterology，2018，154(4):1140-1171.
|
| 81 |
Kim BJ, Kuo B．Gastroparesis and Functional Dyspepsia：A Blurring Distinction of Pathophysiology and Treatment.J Neurogastroenterol Motil，2019，25(1):27-35.
|
| 82 |
Potter MDE, Goodsall TM, Walker MM，et al.Dual histamine blockade for the treatment of adult functional dyspepsia：a single centre experience.Gut，2020，69(5):966.
|
| 83 |
Friesen CA, Sandridge L, Andre L，et al.Mucosal eosinophilia and response to H1/H2 antagonist and cromolyn therapy in pediatric dyspepsia.Clin Pediatr(Phila)，2006，45(2):143-147.
|
| 84 |
Friesen CA, Kearns GL, Andre L，et al.Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia.J Pediatr Gastroenterol Nutr，2004，38(3):343-351.
|
| 85 |
Potter MDE, Wood NK, Walker MM，et al.Proton pump inhibitors and suppression of duodenal eosinophilia in functional dyspepsia.Gut，2019，68(7):1339-1340.
|
| 86 |
Tack J, Talley NJ, Camilleri M，et al.Functional gastroduodenal disorders.Gastroenterology，2006，130(5):1466-1479.
|
| 87 |
Duncanson KR, Talley NJ, Walker MM，et al.Food and functional dyspepsia：a systematic review.J Hum Nutr Diet，2018，31(3):390-407.
|
| 88 |
Acker BW, Cash BD.Medicinal Foods for Functional GI Disorders.Curr Gastroenterol Rep，2017，19(12):62-69.
|
| 89 |
Ciampa BP, Reyes Ramos E, Borum M，et al.The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders.Gastroenterol Hepatol(N Y)，2017，13(2):104-115.
|
| 90 |
Zeng F, Qin W, Ma T，et al.Influence of acupuncture treatment on cerebral activity in functional dyspepsia patients and its relationship with efficacy.Am J Gastroenterol，2012，107(8):1236-1247.
|
| 91 |
Aro P, Talley NJ, Ronkainen J，et al.Anxiety is associated with uninvestigated and functional dyspepsia(Rome III criteria)in a Swedish population-based study.Gastroenterology，2009，137(1):94-100.
|
| 92 |
Hsu YC, Liou JM, Liao SC，et al.Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria.Am J Gastroenterol，2009，104(10):2534-2542.
|
| 93 |
Gathaiya N, Locke GR, 3rd, Camilleri M，et al.Novel associations with dyspepsia：a community-based study of familial aggregation，sleep dysfunction and somatization.Neurogastroenterol Motil，2009，21(9):922-e69.
|
| 94 |
Ford AC, Moayyedi P, Lacy BE, Task Force on the Management of Functional Bowel D．American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.Am J Gastroenterol，2014，109 Suppl 1:S2-26.
|
| 95 |
Calvert EL, Houghton LA, Cooper P，et al.Long-term improvement in functional dyspepsia using hypnotherapy.Gastroenterology，2002，123(6):1778-1785.
|
| 96 |
Orive M, Barrio I, Orive VM，et al.A randomized controlled trial of a 10 week group psychotherapeutic treatment added to standard medical treatment in patients with functional dyspepsia.J Psychosom Res，2015，78(6):563-568.
|
| 97 |
Dehghanizade Z, Zargar Y, Mehrabizadeh Honarmand M，et al.The effectiveness of cognitive behavior stress management on functional dyspepsia symptoms.J Adv Med Educ Prof，2015，3(2):45-49.
|
| 98 |
Faramarzi M, Azadfallah P, Book HE，et al.A randomized controlled trial of brief psychoanalytic psychotherapy in patients with functional dyspepsia.Asian J Psychiatr，2013，6(3):228-234.
|
| 99 |
Hamilton J, Guthrie E, Creed F，et al.A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia.Gastroenterology，2000，119(3):661-669.
|
| 100 |
Xu F, Tan Y, Huang Z，et al.Ameliorating Effect of Transcutaneous Electroacupuncture on Impaired Gastric Accommodation in Patients with Postprandial Distress Syndrome-Predominant Functional Dyspepsia：A Pilot Study.Evid Based Complement Alternat Med，2015，2015:168252.
|
| 101 |
Zhang N, Huang Z, Xu F，et al.Transcutaneous Neuromodulation at Posterior Tibial Nerve and ST36 for Chronic Constipation.Evid Based Complement Alternat Med，2014，2014:560802.
|
| 102 |
Liu Z, Lu D, Guo J，et al.Elevation of Lower Esophageal Sphincter Pressure With Acute Transcutaneous Electrical Acustimulation Synchronized With Inspiration.Neuromodulation，2019，22(5):586-592.
|
| 103 |
Lorena SL, Figueiredo MJ, Almeida JR，et al.Autonomic function in patients with functional dyspepsia assessed by 24-hour heart rate variability.Dig Dis Sci，2002，47(1):27-31.
|
| 104 |
Chen J, Song GQ, Yin J，et al.Electroacupuncture improves impaired gastric motility and slow waves induced by rectal distension in dogs.Am J Physiol Gastrointest Liver Physiol，2008，295(3):G614-620.
|
| 105 |
Ouyang H, Yin J, Wang Z，et al.Electroacupuncture accelerates gastric emptying in association with changes in vagal activity.Am J Physiol Gastrointest Liver Physiol，2002，282(2):G390-396.
|
| 106 |
Liu S, Peng S, Hou X，et al.Transcutaneous electroacupuncture improves dyspeptic symptoms and increases high frequency heart rate variability in patients with functional dyspepsia.Neurogastroenterol Motil，2008，20(11):1204-1211.
|
| 107 |
Ji T, Li X, Lin L，et al.An alternative to current therapies of functional dyspepsia：self-administrated transcutaneous electroacupuncture improves dyspeptic symptoms.Evid Based Complement Alternat Med，2014，2014:832523.
|